Preferred Label : analogs and derivatives;

MeSH synonym : analogs & derivatives; derivatives; related compounds;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-marr/pomalidomide
2025
false
false
false
France
French
risk management
pregnancy
contraception
teratogens
abnormalities, drug-induced
multiple myeloma
pomalidomide
continuity of patient care
Drug-Related side effects and adverse reactions
risk factors
guidelines for drug use
thrombocytopenia
neutropenia
blood cell count
thromboembolism
Infections
patient education handout
pregnancy tests
forms
thalidomide
thalidomide

---
https://ansm.sante.fr/tableau-marr/lutecium-177lu-oxodotreotide
2025
false
false
false
France
French
lutetium Lu 177 dotatate
risk management
patients guideline
lutetium Lu 177 dotatate
infusions, intravenous
radiotherapy
radiopharmaceuticals
radiopharmaceuticals
neuroendocrine tumors
lutetium (177Lu) oxodotreotide
drug information
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide

---
https://ansm.sante.fr/tableau-acces-derogatoire/sirdalud
2025
false
false
false
France
French
summary of product characteristics
Product containing precisely tizanidine (as tizanidine hydrochloride) 4 milligram/1 each conventional release oral tablet (clinical drug)
tizanidine
muscle spasticity
drug information
clonidine
clonidine

---
https://www.cochrane.org/fr/CD000547/CENTRALED_quels-sont-les-benefices-et-les-risques-des-medicaments-administres-avant-une-chirurgie-visant
2025
false
true
false
France
United Kingdom
preoperative care
review of literature
french abstract
leiomyoma
gonadotropin-releasing hormone
uterine myomectomy
hysterectomy

---
https://www.has-sante.fr/jcms/p_3590642/fr/pepaxti-melphalan-flufenamide-myelome-multiple
2025
false
false
false
France
insurance, health, reimbursement
treatment outcome
phenylalanine
antineoplastic agents
melphalan flufenamide
antineoplastic combined chemotherapy protocols
Dexamethasone/Melphalan Flufenamide Regimen
Triple-Class Refractory Multiple Myeloma
evaluation of the transparency committee
melflufen
multiple myeloma
melphalan

---
https://www.ema.europa.eu/en/medicines/human/EPAR/zegalogue
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
dasiglucagon
dasiglucagon
dasiglucagon
drug approval
europe
glucagon
zegalogue
hypoglycemia
adult
child
adolescent
diabetes mellitus
injections, subcutaneous
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
https://www.ema.europa.eu/en/medicines/human/EPAR/emcitate
2025
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
3,3',5-triiodothyroacetic acid
3,3',5-triiodothyroacetic acid
orphan drug production
tiratricol
drug approval
europe
triiodothyronine
thyrotoxicosis
Allan-Herndon-Dudley Syndrome
administration, oral
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
Siiltibcy - Mycobacterium tuberculosis derived antigens (rdESAT-6 / rCFP-10)
https://www.ema.europa.eu/en/medicines/human/EPAR/siiltibcy
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
rdESAT-6
rCFP-10
Mycobacterium tuberculosis, antigen ESAT6, fused with Mycobacterium tuberculosis, antigen CFP10
ESAT-6 protein, mycobacterium tuberculosis
CFP-10 protein, mycobacterium tuberculosis
bacterial proteins
recombinant proteins
antigens, bacterial
mycobacterium tuberculosis
tuberculosis
infant
child
adolescent
adult
drug approval
europe
injections, intradermal
skin tests
drug evaluation, preclinical

---
https://www.has-sante.fr/jcms/p_3601952/fr/seladelpar-gilead-seladelpar-lysine-dihydrate-cholangite-biliaire-primitive
2025
false
false
false
France
Seladelpar Lysine
Seladelpar lysine dihydrate
Primary Biliary Cholangitis
evaluation of the transparency committee
lysine
seladelpar

---
https://www.has-sante.fr/jcms/p_3516789/fr/hydrocortisone-pharmis-succinate-sodique-d-hydrocortisone-corticoide
2024
false
false
false
France
cortisol succinate, sodium salt
hydrocortisone hemisuccinate
anti-inflammatory agents
insurance, health, reimbursement
treatment outcome
injections, intravenous
injections, intramuscular
infusions, intravenous
glucocorticoids
hydrocortisone
emergency treatment
Acute adrenal insufficiency (disorder)
shock
evaluation of the transparency committee
hydrocortisone
corticoids

---
https://ansm.sante.fr/tableau-marr/valproate-et-derives
2024
false
false
false
France
French
risk management
valproate
pregnancy
teratogens
valproate sodium
-
Divalproex Sodium
dipropylacetamide
pregnancy tests
contraception
guideline
patient education handout
forms
developmental disabilities
Contraindications, Drug
valproic acid
valproic acid

---
https://ansm.sante.fr/tableau-marr/lenalidomide
2024
false
false
false
France
French
risk management
pregnancy
contraception
lenalidomide
multiple myeloma
lymphoma, mantle-cell
teratogens
continuity of patient care
drug monitoring
clinical chemistry tests
myelodysplastic syndromes
guidelines for drug use
popular works
venous thromboembolism
Tumor Flare Reaction
neoplasms
Chemical and Drug Induced Liver Injury
angiogenesis inhibitors
angiogenesis inhibitors
thalidomide
thalidomide
thalidomide
Lenalidomide
Lenalidomide

---
https://www.omedit-centre.fr/medias/Codeine-dihydrocodeine_Adulte.pdf
2024
false
false
false
France
French
pain
analgesics, opioid
administration, oral
guidelines for drug use
adult
dihydrocodeine
codeine
codeine

---
https://ansm.sante.fr/informations-de-securite/caspofungine-lansm-recommande-de-ne-pas-utiliser-de-membrane-derivee-du-polyacrylonitrile-chez-les-patients-en-soins-intensifs-sous-hemofiltration
2024
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
Caspofungin
risk management
intensive care
hemofiltration
Lack of drug action (finding)
Hemofiltration system (physical object)
physicochemical incompatibility
polyacrylonitrile

---
https://www.has-sante.fr/jcms/p_3540394/fr/chloraprep-gluconate-de-chlorhexidine-/-alcool-isopropylique-antisepsie
2024
false
false
false
France
drug combinations
insurance, health, reimbursement
administration, cutaneous
Impregnated cutaneous swab
Preoperative disinfection of skin (procedure)
evaluation of the transparency committee
antisepsis
2-Propanol
chlorhexidine gluconate
chlorhexidine

---
https://www.has-sante.fr/jcms/p_3539078/fr/tenkasi-oritavancine-antibacteriens-glycopeptides
2024
false
false
false
France
vancomycin
treatment outcome
insurance, health, reimbursement
oritavancin
Product containing only oritavancin (medicinal product)
staphylococcal skin infections
staphylococcal infections
soft tissue infections
adult
Skin infection caused by Methicillin resistant Staphylococcus aureus (disorder)
infusions, intravenous
evaluation of the transparency committee
anti-bacterial agents
Lipoglycopeptides
oritavancin

---
https://www.has-sante.fr/jcms/p_3538263/fr/chlorhexidine-liberty-pharma-chlorhexidine-anti-infectieux-pour-traitement-oral-local
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
chlorhexidine gluconate
mouthwashes
chlorhexidine
gingivitis
periodontitis
oral surgical procedures
preoperative care
postoperative care
evaluation of the transparency committee
administration, topical
anti-infective agents, local
chlorhexidine

---
https://ansm.sante.fr/actualites/les-autorites-de-sante-alertent-sur-la-circulation-croissante-dopioides-de-synthese-dont-une-nouvelle-classe-particulierement-dangereuse-desormais-inscrite-sur-la-liste-des-stupefiants
2024
false
false
false
France
French
vigilance note
narcotics
Illicit Drugs
france
benzimidazoles
injections
administration, inhalation
administration, intranasal
administration, rectal
drug overdose
drug overdose
antidotes
naloxone
patients guideline
guideline

---
https://www.has-sante.fr/jcms/p_3528756/fr/fluticasone-furoate-teva-furoate-de-fluticasone-rhinite-allergique
2024
false
false
false
France
insurance, health, reimbursement
treatment outcome
administration, intranasal
fluticasone furoate
evaluation of the transparency committee
Fluticasone
Rhinitis, Allergic
fluticasone furoate

---
https://www.has-sante.fr/jcms/p_3491848/fr/giapreza-acetate-d-angiotensine-ii-hypotension-refractaire-dans-les-chocs-distributifs
2024
false
false
false
France
Giapreza
angiotensin II
insurance, health, reimbursement
treatment outcome
vasoconstrictor agents
shock
infusions, intravenous
shock, septic
Distributive shock
adult
Product containing only angiotensin II in parenteral dose form (medicinal product form)
evaluation of the transparency committee
Angiotensin II Acetate
angiotensin II
hypotension

---
https://ansm.sante.fr/informations-de-securite/neofordex-40-mg-dexamethasone-suppression-de-la-barre-de-secabilite-et-de-la-posologie-associee-de-20-mg
https://ansm.sante.fr/actualites/neofordex-40-mg-dexamethasone-attention-au-risque-derreur-medicamenteuse-avec-le-nouveau-comprime-sans-barre-de-secabilite
2023
false
false
false
France
French
drug information
dexamethasone
dexamethasone acetate
dexamethasone
administration, oral
medication errors
pharmacovigilance note

---
https://ansm.sante.fr/actualites/lansm-classe-lhexahydrocannabinol-hhc-et-deux-de-ses-derives-sur-la-liste-des-stupefiants
2023
false
false
false
France
French
legislation
narcotics
cannabinol

---
https://www.has-sante.fr/jcms/p_3444901/fr/biktarvy-emtricitabine-/-bictegravir-/-tenofovir-alafenamide-vih
2023
false
false
false
France
tenofovir alafenamide
treatment outcome
antiviral agents
hiv infections
insurance, health, reimbursement
administration, oral
child
adolescent
HIV-1
emtricitabine, tenofovir alafenamide and bictegravir
evaluation of the transparency committee
bictegravir
Emtricitabine
Tenofovir
bictegravir, emtricitabine, tenofovir alafenamide, drug combination

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-novembre-2023-23-26-octobre
2023
false
false
false
France
French
drug information
risk assessment
thyroid neoplasms
glucagon-like peptide 1
hypoglycemic agents
GLP-1 Mimetics
Glucagon-like peptide-1 (GLP-1) analogues

---
https://ansm.sante.fr/informations-de-securite/esters-ethyliques-dacides-omega-3-risque-accru-et-dose-dependant-de-fibrillation-auriculaire-ou-atriale-chez-des-patients-atteints-de-maladies-cardiovasculaires-ou-presentant-des-facteurs-de-risque-cardiovasculaires
2023
false
false
false
France
French
pharmacovigilance note
risk
Dose-dependent
atrial fibrillation
risk factors
fatty acids, Omega-3
Omega-3-Acid Ethyl Esters

---
https://ansm.sante.fr/tableau-marr/testoserone-undecanoate-de
2023
false
false
false
France
French
guidelines for drug use
testosterone undecanoate
testosterone
testosterone
testosterone
Solubilizing Excipient
Drug-Related side effects and adverse reactions
Pulmonary oil microembolism (disorder)

---
https://ansm.sante.fr/actualites/creation-dun-comite-scientifique-temporaire-pour-analyser-lusage-des-analogues-du-glp-1
2023
false
false
false
France
French
drug utilization
drug utilization review
GLP-1 Mimetics
Glucagon-like peptide-1 (GLP-1) analogues
glucagon-like peptide 1
Off-Label use
drug information

---
https://www.has-sante.fr/jcms/p_3479053/fr/testosterone-besins-testosterone-hypogonadisme-masculin
2023
false
false
false
France
eunuchoidism
testosterone undecanoate
treatment outcome
insurance, health, reimbursement
hormone replacement therapy
testosterone
testosterone
androgens
evaluation of the transparency committee
eunuchism
testosterone

---
https://pgtmsite.files.wordpress.com/2024/01/ad_covid-ambulatoire-pediatrie_vf2_20230405.pdf
https://pgtmsite.files.wordpress.com/2024/01/poster_covid-adulte-et-ped_apes_-2023_final-1.pdf
2023
false
false
false
Canada
antibodies, monoclonal, humanized
antibodies, neutralizing
alanine
adenosine monophosphate
ribonucleotides
pediatrics
alanine
adenosine monophosphate
ribonucleotides
guidelines for drug use
remdesivir
sotrovimab
outpatients
hospitals, university
COVID-19
quebec

---
https://www.has-sante.fr/jcms/p_3416571/fr/imcivree-setmelanotide-pomc
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
anti-obesity agents
setmelanotide
adult
child
adolescent
obesity
proopiomelanocortin deficiency
Obesity due to leptin receptor gene deficiency
Prohormone Convertase 1 Deficiency
Leptin Receptor Deficiency
evaluation of the transparency committee
alpha-msh
setmelanotide

---
https://ansm.sante.fr/actualites/diabete-de-type-2-et-tensions-dapprovisionnement-conduite-a-tenir-pour-la-prescription-des-analogues-de-glp1
2023
false
false
false
France
French
incretins
Glucagon-Like Peptide-1 Receptor
guideline
semaglutide
semaglutide
continuity of patient care
hypoglycemic agents
diabetes mellitus, type 2
guidelines for drug use
Liraglutide
break in supply
liraglutide

---
https://www.has-sante.fr/jcms/p_3375776/fr/flucortac-acetate-de-fludrocortisone
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
pharmaceutical solutions
fludrocortisone
addison disease
adrenal hyperplasia, congenital
hypotension, orthostatic
Mineralocorticoid deficiency (disorder)
drug therapy, combination
Salt-losing congenital adrenal hyperplasia (disorder)
Neurogenic Orthostatic Hypotension
evaluation of the transparency committee
fludrocortisone acetate
fludrocortisone

---
https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/remdesivir.html
2022
false
false
false
Canada
French
drug evaluation
treatment outcome
remdesivir
Remdesivir
antiviral agents
Evidence-Based medicine
remdesivir
alanine
alanine
ribonucleotides
pneumonia, viral
coronavirus infections
pandemics
COVID-19

---
https://www.has-sante.fr/jcms/p_3389403/fr/wynzora-calcipotriol/betamethasone-psoriasis
2022
false
false
false
France
drug combinations
treatment outcome
insurance, health, reimbursement
ointments
administration, cutaneous
calcipotriene
betamethasone dipropionate, calcipotriol drug combination
betamethasone
betamethasone-17,21-dipropionate
anti-inflammatory agents
calcipotriol, combinations
dermatologic agents
scalp dermatoses
Psoriasis of scalp (disorder)
Product containing only betamethasone and calcipotriol in cutaneous dose form (medicinal product form)
adult
evaluation of the transparency committee
psoriasis

---
https://conseil-scientifique.public.lu/fr/publications/covid-19/molnupiravir.html
2022
false
false
false
Luxembourg
COVID-19
hydroxylamines
cytidine
molnupiravir
practice guideline
molnupiravir

---
http://publications.msss.gouv.qc.ca/msss/document-002023/
http://publications.msss.gouv.qc.ca/msss/document-002024/
http://publications.msss.gouv.qc.ca/msss/document-002025/
2022
false
false
false
Canada
French
practice guideline
patient care management
hepatitis C
quebec
hepatitis C
hepatitis C
antiviral agents
continuity of patient care
antiviral agents
drug interactions
acute disease
drug monitoring
hepatitis C, chronic
hepatitis C antibodies
hepatitis C
serologic tests
fibrosis, liver
predictive value of tests
elbasvir-grazoprevir drug combination
glecaprevir
pibrentasvir
ledipasvir, sofosbuvir drug combination
drug combinations
sofosbuvir-velpatasvir drug combination
voxilaprevir
liver cirrhosis
glecaprevir
quinoxalines
sulfonamides
benzofurans
drug combinations
imidazoles
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
Sofosbuvir
carbamates
Heterocyclic Compounds, 4 or More Rings
macrocyclic compounds

---
https://www.ema.europa.eu/en/medicines/human/EPAR/yselty
2022
false
false
false
Netherlands
French
English
Linzagolix Choline
Linzagolix Choline
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
linzagolix
drug approval
europe
adult
leiomyoma
administration, oral
drug therapy, combination
pregnancy
breast feeding
drug interactions
Gonadotropin releasing hormone receptor antagonist (disposition)
receptors, LHRH
linzagolix
product surveillance, postmarketing
drug evaluation, preclinical

---
https://www.ema.europa.eu/en/medicines/human/EPAR/nexviadyme
2022
false
false
false
Netherlands
French
drug approval
europe
avalglucosidase alfa
Avalglucosidase Alfa
Avalglucosidase Alfa
orphan drug production
glycogen storage disease type ii
drug evaluation
summary of product characteristics
syndication feed
package leaflet
enzyme replacement therapy
alpha-Glucosidases
infusions, intravenous
risk management
product surveillance, postmarketing
recombinant proteins
aged
pregnancy
drug evaluation, preclinical

---
https://www.has-sante.fr/jcms/p_3375773/fr/fludrocortisone-acetate-accord-acetate-de-fludrocortisone
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
addison disease
Mineralocorticoid deficiency (disorder)
adrenal hyperplasia, congenital
Salt-losing congenital adrenal hyperplasia (disorder)
drug therapy, combination
glucocorticoids
fludrocortisone
evaluation of the transparency committee
fludrocortisone acetate
fludrocortisone

---
https://www.has-sante.fr/jcms/p_3372794/fr/ultarcorlene-pivalate-de-prednisolone
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, ophthalmic
anti-inflammatory agents
prednisolone
ocular inflammation
mecortolon
evaluation of the transparency committee
prednisolone

---
https://www.has-sante.fr/jcms/p_3242941/fr/otezla
2021
false
false
false
France
insurance, health, reimbursement
treatment outcome
administration, oral
apremilast
adult
Behcet syndrome
Behçet's disease affecting oral mucosa (disorder)
oral ulcer
anti-inflammatory agents, non-steroidal
buccal ulcerations due to Behçet's disease
evaluation of the transparency committee
apremilast
thalidomide

---
https://www.has-sante.fr/jcms/p_3243899/fr/frakidex
2021
false
false
false
France
insurance, health, reimbursement
treatment outcome
administration, ophthalmic
drug combinations
framycetin
dexamethasone
dexamethasone sodium phosphate
Neomycin B Sulfate
anti-bacterial agents
glucocorticoids
dexamethasone and antiinfectives
ophthalmologic surgical procedures
postoperative care
postoperative complications
eye infections, bacterial
evaluation of the transparency committee
dexamethasone 21-phosphate
dexamethasone

---
https://www.has-sante.fr/jcms/p_3243902/fr/chibro-cadron
2021
false
false
false
France
insurance, health, reimbursement
treatment outcome
administration, ophthalmic
drug combinations
dexamethasone 21-phosphate
glucocorticoids
anti-inflammatory agents
anti-bacterial agents
Neomycin Sulfate
dexamethasone and antiinfectives
ophthalmologic surgical procedures
postoperative complications
eye infections, bacterial
evaluation of the transparency committee
neomycin
dexamethasone
dexamethasone

---
https://www.has-sante.fr/jcms/p_3258964/fr/givlaari
2021
false
false
false
France
Givosiran
givosiran
acetylgalactosamine
pyrrolidines
insurance, health, reimbursement
adult
porphyria, acute hepatic
injections, subcutaneous
evaluation of the transparency committee
porphyrias, hepatic
porphobilinogen synthase
porphobilinogen synthase
givosiran

---
https://www.has-sante.fr/jcms/p_3259937/fr/selincro
2021
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
nalmefene hydrochloride
administration, oral
adult
alcoholism
alcohol drinking
nalmefene
nalmefene
naltrexone
naltrexone

---
https://www.ema.europa.eu/en/medicines/human/EPAR/sogroya
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Somapacitan
Somapacitan
human growth hormone
human growth hormone
orphan drug production
hormone replacement therapy
adult
Growth Hormone Deficiency
injections, subcutaneous
product surveillance, postmarketing
Adult growth hormone deficiency (disorder)
aged
drug interactions
pregnancy
breast feeding
somapacitan
human growth hormone
Prolonged-Action preparations
drug evaluation, preclinical
Product containing only somapacitan in parenteral dose form (medicinal product form)
Delayed-Action preparations

---
https://www.ema.europa.eu/en/medicines/human/EPAR/vazkepa
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
eicosapentaenoic acid ethyl ester
eicosapentaenoic acid ethyl ester
eicosapentaenoic acid
omega-3-triglycerides incl. other esters and acids
cardiovascular diseases
adult
administration, oral
lipid regulating agents
lipid regulating agents
risk factors
hypertriglyceridemia
drug therapy, combination
hydroxymethylglutaryl-coa reductase inhibitors
pregnancy
breast feeding
dyslipidemias
drug evaluation, preclinical

---
https://www.has-sante.fr/jcms/p_3262661/fr/chlorhexidine-digluconate-/-alcool-isopropylique-gilbert-healthcare-chlorhexidine-digluconate/alcool-isopropylique
2021
false
false
false
France
chlorhexidine, combinations
administration, cutaneous
drug combinations
anti-infective agents, local
dermatologic agents
preoperative care
Preoperative disinfection of skin (procedure)
pharmaceutical solutions
evaluation of the transparency committee
chlorhexidine gluconate
chlorhexidine
2-Propanol

---
https://www.has-sante.fr/jcms/p_3262271/fr/enstilar-calcipotriol-betamethasone
2021
false
false
false
France
betamethasone-17,21-dipropionate
treatment outcome
insurance, health, reimbursement
administration, cutaneous
calcipotriol, combinations
anti-inflammatory agents
glucocorticoids
adult
psoriasis
evaluation of the transparency committee
calcipotriene
betamethasone
calcitriol

---
https://www.has-sante.fr/jcms/p_3262649/fr/kardegic-acetylsalicylate-de-dl-lysine
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
platelet aggregation inhibitors
acetylsalicylic acid
Lower limb occlusive arterial disease
Lower limb occlusive arterial disease
lower extremity
arterial occlusive diseases
arterial occlusive diseases
evaluation of the transparency committee
lysine
Solusprin, monosalicylate, (DL-Lys)-isomer
acetylsalicylic acid lysinate
aspirin

---
https://www.ema.europa.eu/en/medicines/human/EPAR/enhertu
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Trastuzumab Deruxtecan
Trastuzumab Deruxtecan
drug approval
europe
trastuzumab deruxtecan
Tyrosine Kinase Inhibitors
infusions, intravenous
antineoplastic agents
pregnancy
breast feeding
drug interactions
drug monitoring
adult
breast neoplasms
neoplasm metastasis
Unresectable Breast Carcinoma
aged
receptor, erbB-2
drug evaluation, preclinical
trastuzumab deruxtecan
trastuzumab deruxtecan
antineoplastic agents
camptothecin
immunoconjugates
antibodies, monoclonal, humanized
Trastuzumab
immunoconjugates
antibodies, monoclonal, humanized
Trastuzumab

---
https://ansm.sante.fr/actualites/traitement-du-cancer-du-sein-triple-negatif-lansm-delivre-de-nouvelles-atu-nominatives-pour-trodelvy-sacituzumab-govitecan
2021
false
false
false
France
French
triple negative breast neoplasms
sacituzumab govitecan
Product containing only sacituzumab govitecan (medicinal product)
drug information
sacituzumab govitecan
camptothecin
camptothecin
immunoconjugates
antibodies, monoclonal, humanized

---
https://www.ema.europa.eu/en/medicines/human/EPAR/onivyde-pegylated-liposomal
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Metastatic Pancreatic Adenocarcinoma
neoplasm metastasis
Pegylated Liposomal Irinotecan
Pegylated Liposomal Irinotecan
liposomes
pancreatic neoplasms
irinotecan sucrosofate
irinotecan sucrosofate
antineoplastic agents
antineoplastic agents
pregnancy
breast feeding
drug interactions
antineoplastic combined chemotherapy protocols
fluorouracil
leucovorin
Fluorouracil/Liposomal Irinotecan/Leucovorin Regimen
orphan drug production
infusions, intravenous
topoisomerase I inhibitors
topoisomerase I inhibitors
aged
DNA topoisomerases, type I
survival analysis
drug evaluation, preclinical
drug approval
europe
Irinotecan hydrochloride trihydrate (substance)
adult
adenocarcinoma
camptothecin
camptothecin
drug combinations
sucrose
sucrose
camptothecin
drug combinations
sucrose

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66874153
2021
false
false
false
France
French
entecavir
summary of product characteristics
package leaflet
guanine
guanine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63322961
2021
false
false
false
France
French
drug combinations
package leaflet
summary of product characteristics
dexketoprofen trometamol
tramadol hydrochloride
tramadol
ketoprofen
ketoprofen
tromethamine

---
https://ansm.sante.fr/tableau-atu-rtu/voxzogo-0-4-mg-poudre-et-solvant-pour-solution-injectable-voxzogo-0-56-mg-poudre-et-solvant-pour-solution-injectable-voxzogo-1-2-mg-poudre-et-solvant-pour-solution-injectable
2021
false
false
false
France
French
guidelines for drug use
vosoritide
vosoritide
child
achondroplasia
package leaflet
vosoritide
natriuretic peptide, C-type
natriuretic peptide, C-type
natriuretic peptide, C-type

---
https://www.has-sante.fr/jcms/p_3272596/fr/enhertu-trastuzumab-deruxtecan
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
trastuzumab deruxtecan
adult
breast neoplasms
HER2-Positive Breast Carcinoma
neoplasm metastasis
infusions, intravenous
evaluation of the transparency committee
trastuzumab deruxtecan
Trastuzumab
camptothecin
immunoconjugates
antibodies, monoclonal, humanized

---
https://ansm.sante.fr/tableau-atu-rtu/xtandi-40-mg-comprime-pellicule
2021
false
true
false
France
French
guidelines for drug use
summary of product characteristics
package leaflet
administration, oral
enzalutamide
prostatic neoplasms
neoplasms, hormone-dependent
neoplasm metastasis
adult
antineoplastic agents, hormonal
enzalutamide
phenylthiohydantoin
phenylthiohydantoin

---
https://www.cadth.ca/fr/sacituzumab-govitecan
2021
false
false
false
Canada
French
drug information
triple negative breast neoplasms
sacituzumab govitecan
sacituzumab govitecan
camptothecin
camptothecin
immunoconjugates
antibodies, monoclonal, humanized

---
https://presse.inserm.fr/publication-de-lexpertise-collective-inserm-pesticides-et-effets-sur-la-sante-nouvelles-donnees/43303
2021
false
false
false
France
French
journal article
chlordecone
insecticides
herbicides
glyphosate
antifungal agents
succinate dehydrogenase
adult
child
parkinson disease
multiple myeloma
prostatic neoplasms
lymphoma, Non-Hodgkin
pulmonary disease, chronic obstructive
cognition disorders
pregnancy
succinate dehydrogenase inhibitors
glycine
glycine

---
https://www.ema.europa.eu/en/medicines/human/EPAR/imcivree
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
centrally acting antiobesity products
anti-obesity agents
anti-obesity agents
adult
child
adolescent
Obesity due to leptin receptor gene deficiency
obesity
obesity
Obesity due to pro-opiomelanocortin deficiency
orphan drug production
pro-opiomelanocortin
Pro-Opiomelanocortin Deficiency
Leptin Receptor Deficiency
receptors, leptin
injections, subcutaneous
drug monitoring
pregnancy
breast feeding
receptor, melanocortin, type 4
drug evaluation, preclinical
proopiomelanocortin deficiency
setmelanotide
setmelanotide
alpha-msh
alpha-msh
alpha-msh

---
https://www.cochrane.org/fr/CD014962/HAEMATOL_remdesivir-dans-le-traitement-des-personnes-atteintes-de-la-covid-19
2021
false
false
false
France
United Kingdom
COVID-19
adenosine monophosphate
alanine
antiviral agents
review of literature
french abstract
remdesivir

---
https://www.has-sante.fr/jcms/p_3283449/fr/komboglyze-metformine-/-saxagliptine
2021
false
false
false
France
evaluation of the transparency committee
saxagliptin
metformin
dipeptides
adamantane
metformin and saxagliptin
treatment outcome
insurance, health, reimbursement
drug combinations
Saxagliptin Hydrochloride
Metformin Hydrochloride
diabetes mellitus, type 2
hypoglycemic agents
drug therapy, combination
administration, oral
adult
incretins
dipeptidyl-peptidase iv inhibitors

---
https://www.has-sante.fr/jcms/p_3283452/fr/onglyza-saxagliptine-chlorhydrate-de
2021
false
false
false
France
evaluation of the transparency committee
saxagliptin
dipeptides
adamantane
treatment outcome
administration, oral
diabetes mellitus, type 2
Saxagliptin Hydrochloride
hypoglycemic agents
incretins
dipeptidyl-peptidase iv inhibitors
saxagliptin
drug therapy, combination
insurance, health, reimbursement

---
https://ansm.sante.fr/actualites/traitement-du-cancer-du-sein-triple-negatif-autorisation-en-acces-precoce-du-medicament-trodelvy-sacituzumab-govitecan
2021
false
false
false
France
French
sacituzumab govitecan
drug information
drug approval
france
triple negative breast neoplasms
sacituzumab govitecan
camptothecin
camptothecin
immunoconjugates
antibodies, monoclonal, humanized

---
https://www.has-sante.fr/jcms/p_3284598/fr/trodelvy-180-mg-sacituzumab-govitecan
2021
false
false
false
France
sacituzumab govitecan
evaluation of the transparency committee
sacituzumab govitecan
camptothecin
immunoconjugates
antibodies, monoclonal, humanized
treatment outcome
drug approval
france
adult
antineoplastic agents
triple negative breast neoplasms
infusions, intravenous
Product containing only sacituzumab govitecan in parenteral dose form (medicinal product form)
Metastatic Triple-Negative Breast Carcinoma
Unresectable Triple-Negative Breast Carcinoma

---
https://presse.inserm.fr/absence-defficacite-du-remdesivir-chez-les-patients-hospitalises-atteints-de-covid-19-et-poursuite-de-lessai-discovery-pour-tester-un-nouveau-medicament-antiviral/43790
2021
false
false
false
France
French
journal article
coronavirus infections
alanine
alanine
ribonucleotides
adenosine monophosphate
adenosine monophosphate
COVID-19
treatment outcome
remdesivir
antiviral agents
medical futility
Lack of drug action (finding)
inpatients

---
https://www.cadth.ca/fr/ripretinib
2021
false
false
false
Canada
French
English
drug evaluation
naphthyridines
urea
urea
ripretinib
gastrointestinal stromal tumors
canada

---
https://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=68106914
2021
false
false
false
France
French
summary of product characteristics
package leaflet
dexamethasone 21-phosphate
dexamethasone
dexamethasone
dexamethasone sodium phosphate
administration, ophthalmic
dexamethasone

---
https://ansm.sante.fr/informations-de-securite/champix-varenicline-rappel-de-lots-en-raison-de-la-presence-de-limpurete-n-nitrosovarenicline-a-un-taux-superieur-a-la-limite-acceptable
2021
false
false
false
France
French
pharmacovigilance note
Varenicline
drug contamination
nitrosamines

---
https://www.has-sante.fr/jcms/p_3186049/fr/veille-des-etudes-cliniques-publiees-pour-certains-medicaments-du-covid-19
2021
false
false
false
France
coronavirus infections
pneumonia, viral
review of literature
hydroxychloroquine
remdesivir
lopinavir-ritonavir drug combination
Clinical Studies as Topic
azithromycin
remdesivir
pneumonia, viral
coronavirus infections
pandemics
alanine
alanine
ribonucleotides
ritonavir
lopinavir
drug combinations
COVID-19

---
https://www.cbip.be/fr/articles/3510?folia=3503
2021
false
false
false
Belgium
French
journal article
hydroxychloroquine
Remdesivir
remdesivir
lopinavir
Interferon beta-1a
treatment outcome
inpatients
controlled clinical trials as topic
pneumonia, viral
coronavirus infections
pandemics
coronavirus infections
alanine
alanine
ribonucleotides
pneumonia, viral
coronavirus infections
pandemics
COVID-19
COVID-19

---
https://www.has-sante.fr/jcms/p_3223297/fr/sarclisa
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
infusions, intravenous
isatuximab
adult
antineoplastic combined chemotherapy protocols
multiple myeloma
Dexamethasone/Isatuximab/Pomalidomide Regimen
dexamethasone
pomalidomide
Refractory Multiple Myeloma
Recurrent Multiple Myeloma
isatuximab
isatuximab
evaluation of the transparency committee
antibodies, monoclonal
antibodies, monoclonal
thalidomide
thalidomide
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized

---
https://cadth.ca/fr/propionate-dhalobetasol-et-tazarotene-0
2021
false
false
false
Canada
French
drug evaluation
drug combinations
psoriasis
tazarotene
halobetasol
tazarotene and ulobetasol
dermatologic agents
adult
canada
insurance, health, reimbursement
halobetasol propionate
administration, cutaneous
nicotinic acids
clobetasol
clobetasol

---
https://ansm.sante.fr/informations-de-securite/prodilantin-75-mg-ml-fosphenytoine-sodique-equivalent-a-50-mg-ml-de-phenytoine-sodique-ep-nouvelle-diffusion-des-guides-posologiques-adulte-et-enfant-afin-deviter-lutilisation-chez-les-enfants-de-moins-de-5-ans-et-les-erreurs-medicamenteuses
2021
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
medication errors
fosphenytoin sodium
adult
child
status epilepticus
emergency treatment
anticonvulsants
fosphenytoin
administration, intravenous
continuity of patient care
fosphenytoin
phenytoin
phenytoin

---
https://www.ema.europa.eu/en/medicines/human/EPAR/roclanda
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
latanoprost and netarsudil
drug combinations
Latanoprost
Latanoprost
antihypertensive agents
antihypertensive agents
adult
glaucoma, open-angle
ocular hypertension
administration, ophthalmic
ophthalmic solutions
rho-Associated kinases
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Product containing only latanoprost and netarsudil (medicinal product)
netarsudil
netarsudil
benzoates
beta-Alanine
beta-Alanine
benzoates
beta-Alanine

---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/duratocin-5626.html
2021
false
false
false
Canada
French
drug evaluation
quebec
carbetocin
postpartum hemorrhage
carbetocin
oxytocin
oxytocin

---
https://www.has-sante.fr/jcms/p_3240421/fr/carbetocine-aguettant
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
carbetocin
injections, intravenous
injections, intramuscular
uterine inertia
postpartum hemorrhage
Atonic postpartum hemorrhage (disorder)
oxytocics
Vaginal Delivery
evaluation of the transparency committee
carbetocin
oxytocin
oxytocin

---
https://www.has-sante.fr/jcms/p_3240418/fr/rydapt
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
midostaurin
antineoplastic agents
protein kinase inhibitors
administration, oral
midostaurin
adult
aggressive systemic mastocytosis
Systemic mastocytosis with associated hematologic neoplasm
evaluation of the transparency committee
mastocytosis, systemic
staurosporine
staurosporine

---
https://www.has-sante.fr/upload/docs/application/pdf/2021-02/veille_covid_fevrier_2021.pdf
2021
false
false
false
France
French
drug information
scientific and technical information
review of literature
remdesivir
dexamethasone
glucocorticoids
COVID-19-Associated Acute Respiratory Distress Syndrome
cytokine storm syndrome
antiviral agents
lopinavir-ritonavir drug combination
azithromycin
hydroxychloroquine
tocilizumab
interleukin 1 receptor antagonist protein
treatment outcome
canakinumab
Post-Exposure prophylaxis
antibodies, monoclonal, humanized
Etesevimab
Bamlanivimab
Casirivimab
Imdevimab
Casirivimab/Imdevimab
colchicine
ivermectin
vitamin D
COVID-19 Convalescent Plasma
bamlanivimab
cytokine storm syndrome in COVID-19
alanine
alanine
ribonucleotides
pandemics
antibodies, monoclonal
ritonavir
lopinavir
drug combinations
immunization, passive
COVID-19
COVID-19
COVID-19

---
https://www.has-sante.fr/jcms/p_3148406/fr/neofordex
2020
false
false
false
France
dexamethasone acetate
administration, oral
dexamethasone
evaluation of the transparency committee
dexamethasone
dexamethasone

---
https://www.has-sante.fr/jcms/p_3225392/fr/trulicity
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
diabetes mellitus, type 2
injections, subcutaneous
hypoglycemic agents
adult
drug therapy, combination
Product containing only dulaglutide (medicinal product)
evaluation of the transparency committee
dulaglutide
immunoglobulin fc fragments
recombinant fusion proteins
glucagon-like peptides
immunoglobulin fc fragments
recombinant fusion proteins

---
https://www.has-sante.fr/jcms/p_3151440/fr/sawis
2020
false
false
false
France
treatment outcome
drugs, generic
dienogest
administration, oral
dienogest
endometriosis
progestins
evaluation of the transparency committee
nandrolone
nandrolone

---
https://www.has-sante.fr/jcms/p_3152635/fr/harvoni
2020
false
false
false
France
Sofosbuvir
treatment outcome
ledipasvir
ledipasvir, sofosbuvir drug combination
adult
adolescent
antiviral agents
drug combinations
hepatitis C, chronic
evaluation of the transparency committee
Harvoni
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate

---
https://www.has-sante.fr/jcms/p_3152701/fr/xenetix
2020
false
false
false
France
iobitridol
evaluation of the transparency committee
iobitridol
iohexol
iohexol

---
https://ansm.sante.fr/informations-de-securite/mepact-4-mg-mifamurtide-attention-au-risque-de-dysfonctionnement-ou-de-fuite-du-filtre-lors-de-la-reconstitution
2020
false
false
false
France
French
mifamurtide
equipment failure analysis
Medical Device Failure or Malfunction
phosphatidylethanolamines
acetylmuramyl-alanyl-isoglutamine
acetylmuramyl-alanyl-isoglutamine

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=771
2020
false
false
false
France
coronavirus infections
coronavirus infections
pneumonia, viral
pneumonia, viral
practice guideline
coronavirus infections
coronavirus infections
disease transmission, infectious
coronavirus infections
signs and symptoms
adult
child
pregnancy
pneumonia, viral
risk factors
remdesivir
Remdesivir
hospitalization
coronavirus infections
lopinavir-ritonavir drug combination
chloroquine
antiviral agents
severity of illness index
continuity of patient care
coronavirus infections
COVID-19
public health guidelines
patient care management
alanine
alanine
ribonucleotides
ritonavir
lopinavir
drug combinations
pneumonia, viral
COVID-19

---
https://www.has-sante.fr/jcms/p_3161436/fr/imnovid
2020
false
false
false
France
pomalidomide
pomalidomide
antineoplastic combined chemotherapy protocols
adult
multiple myeloma
dexamethasone
Bortezomib
treatment outcome
survival analysis
angiogenesis inhibitors
administration, oral
evaluation of the transparency committee
thalidomide
thalidomide

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=785
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=787
2020
false
false
false
France
Off-Label use
severity of illness index
oxygen inhalation therapy
hospitalization
lopinavir-ritonavir drug combination
remdesivir
Remdesivir
hydroxychloroquine
Respiratory Distress Syndrome
antiviral agents
azithromycin
drug interactions
drug monitoring
antiviral agents
antiviral agents
practice guideline
adult
aged
hypoxemia
signs and symptoms
risk factors
reverse transcriptase polymerase chain reaction
clinical trials as topic
public health guidelines
case management
pneumonia, viral
coronavirus infections
Hypoxia
pneumonia, viral
coronavirus infections
pneumonia, viral
coronavirus infections
ritonavir
lopinavir
drug combinations
alanine
alanine
ribonucleotides
pneumonia, viral
coronavirus infections
COVID-19
COVID-19
COVID-19
COVID-19

---
https://www.has-sante.fr/jcms/p_3164675/fr/etopophos
2020
false
false
false
France
antineoplastic agents, phytogenic
infusions, parenteral
insurance, health, reimbursement
treatment outcome
etoposide
evaluation of the transparency committee
etoposide phosphate
organophosphorus compounds
etoposide

---
https://www.ansm.sante.fr/actualites/medicaments-antitussifs-a-base-de-pholcodine-et-risque-de-reaction-allergique-aux-curares-dans-le-contexte-de-lepidemie-de-covid-19
2020
false
false
false
France
French
antitussive agents
pholcodine
cross reactions
neuromuscular blocking agents
drug hypersensitivity
pharmacovigilance note
cough
anaphylaxis
morpholines
codeine
codeine
pneumonia, viral
coronavirus infections
pandemics
COVID-19

---
https://www.ema.europa.eu/en/medicines/human/EPAR/givlaari
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
Givosiran
Givosiran
acetylgalactosamine
pyrrolidines
acute disease
porphyrias, hepatic
drug approval
europe
product surveillance, postmarketing
adult
adolescent
injections, subcutaneous
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
porphyria, acute hepatic
givosiran
porphobilinogen synthase
porphobilinogen synthase
givosiran
givosiran

---
https://www.ema.europa.eu/en/medicines/human/EPAR/trepulmix
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treprostinil
treprostinil
treprostinil
Chronic thromboembolic pulmonary hypertension
chronic disease
orphan drug production
hypertension, pulmonary
pulmonary thromboembolisms
infusions, intravenous
drug interactions
pregnancy
breast feeding
vasodilator agents
vasodilator agents
adult
aged
drug evaluation, preclinical
pulmonary embolism
epoprostenol
epoprostenol
epoprostenol

---
https://www.has-sante.fr/jcms/p_3186479/fr/dotarem
2020
false
false
false
France
gadolinium
gadoteric acid
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3186712/fr/ocaliva
2020
false
false
false
France
obeticholic acid
adult
insurance, health, reimbursement
treatment outcome
drug therapy, combination
ursodeoxycholic acid
Primary biliary cholangitis
Primary Biliary Cholangitis
administration, oral
evaluation of the transparency committee
obeticholic acid
chenodeoxycholic acid
liver cirrhosis, biliary
chenodeoxycholic acid
chenodeoxycholic acid

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=847
2020
false
false
true
France
pneumonia, viral
coronavirus infections
hydroxychloroquine
lopinavir-ritonavir drug combination
Remdesivir
remdesivir
clinical trials as topic
Symptomatic treatment
public health guidelines
pandemics
pneumonia, viral
coronavirus infections
pandemics
ritonavir
lopinavir
drug combinations
alanine
alanine
ribonucleotides
COVID-19

---
https://www.ema.europa.eu/en/medicines/human/EPAR/sunosi
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
administration, oral
disorders of excessive somnolence
narcolepsy
sleep apnea, obstructive
solriamfetol
Solriamfetol
Solriamfetol
carbamates
carbamates
phenylalanine
product surveillance, postmarketing
adult
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
solriamfetol
solriamfetol

---
https://www.has-sante.fr/jcms/p_3188469/fr/pabal
2020
false
false
false
France
carbetocin
insurance, health, reimbursement
Atonic postpartum hemorrhage (disorder)
postpartum hemorrhage
uterine inertia
oxytocics
evaluation of the transparency committee
carbetocin
oxytocin

---
https://www.ema.europa.eu/en/medicines/human/EPAR/sarclisa
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
orphan drug production
antineoplastic combined chemotherapy protocols
pomalidomide
dexamethasone
antineoplastic agents
antineoplastic agents
multiple myeloma
adult
infusions, intravenous
CD38 protein, human
product surveillance, postmarketing
recurrence
aged
pregnancy
breast feeding
isatuximab
survival analysis
Recurrent Multiple Myeloma
Refractory Multiple Myeloma
Dexamethasone/Isatuximab/Pomalidomide Regimen
isatuximab
isatuximab
antibodies, monoclonal
antibodies, monoclonal
thalidomide
thalidomide
membrane glycoproteins
ADP-ribosyl Cyclase 1
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=854
2020
false
false
false
France
pneumonia, viral
coronavirus infections
Remdesivir
remdesivir
antiviral agents
remdesivir
treatment outcome
risk assessment
Clinical Studies as Topic
antiviral agents
remdesivir
public health guidelines
pneumonia, viral
coronavirus infections
pandemics
alanine
alanine
ribonucleotides
alanine
ribonucleotides
COVID-19

---
https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/remdesivir.html
2020
false
false
false
Canada
French
guidelines for drug use
treatment outcome
remdesivir
Remdesivir
antiviral agents
canada
remdesivir
alanine
alanine
ribonucleotides
pneumonia, viral
coronavirus infections
pandemics
coronavirus infections
COVID-19

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=866
2020
false
false
false
France
coronavirus infections
pneumonia, viral
standard of care
chloroquine
hydroxychloroquine
remdesivir
lopinavir-ritonavir drug combination
immunotherapy
siltuximab
tocilizumab
sarilumab
umifenovir
convalescent plasma
dexamethasone
public health guidelines
pneumonia, viral
coronavirus infections
pandemics
alanine
alanine
ribonucleotides
ritonavir
lopinavir
drug combinations
pneumonia, viral
coronavirus infections
pandemics
antibodies, monoclonal
antibodies, monoclonal, humanized
indoles
COVID-19
COVID-19

---
https://www.has-sante.fr/jcms/p_3191915/fr/givlaari
2020
false
false
false
France
Givosiran
Givosiran
acetylgalactosamine
pyrrolidines
givosiran
injections, subcutaneous
treatment outcome
insurance, health, reimbursement
adult
porphyrias, hepatic
acute disease
porphyria, acute hepatic
guidelines for drug use
continuity of patient care
evaluation of the transparency committee
porphobilinogen synthase
porphobilinogen synthase
givosiran
givosiran

---
https://www.irsst.qc.ca/publications-et-outils/publication/i/101079/n/effets-pesticides-agricoles-quebec
2020
false
false
false
Canada
pesticides
occupational exposure
occupational diseases
2,4-dichlorophenoxyacetic acid
atrazine
bromoxynil
captan
Evidence-Based medicine
carfentrazone-ethyl
chlorantranilipole
tetrachloroisophthalonitrile
chlorpyrifos
cyantraniliprole
cypermethrin
dicamba
glufosinate
glyphosate
hexazinone
malathion
mancozeb
metiram
sodium methyldithiocarbamate
clothianidin
imidacloprid
Thiamethoxam
paraquat
pyrachlostrobin
metolachlor
spinosad
technical report
pesticides
quebec
phosphinothricin
polymarcine
methyldithiocarbamate
aminobutyrates
ditiocarb
thiocarbamates
nitriles
triazoles
ortho-Aminobenzoates
pyrazoles
pyrethrins
glycine
glycine
triazines
maneb
zineb
guanidines
thiazoles
Neonicotinoids
imidazoles
nitro compounds
carbamates
Strobilurins
acetamides
macrolides
drug combinations

---
https://www.has-sante.fr/jcms/p_3191469/fr/spravato
2020
false
false
false
France
esketamine
insurance, health, reimbursement
treatment outcome
adult
drug therapy, combination
depressive disorder, Treatment-Resistant
Esketamine
ketamine
antidepressive agents
administration, intranasal
Esketamine
antidepressive agents
evaluation of the transparency committee
Esketamine
Esketamine

---
https://www.has-sante.fr/jcms/p_3193178/fr/sunosi
2020
false
false
false
France
Solriamfetol
Solriamfetol
administration, oral
solriamfetol
insurance, health, reimbursement
phenylalanine
carbamates
adult
narcolepsy
Excessive daytime sleepiness
sleep apnea, obstructive
treatment outcome
evaluation of the transparency committee
solriamfetol
solriamfetol

---
https://www.ansm.sante.fr/actualites/covid-19-octroi-dune-atu-de-cohorte-pour-le-medicament-remdesivir-afin-que-les-patients-puissent-continuer-a-en-beneficier-en-france
2020
false
false
false
France
French
drug information
france
Remdesivir
antiviral agents
remdesivir
hospitals
adult
adolescent
guidelines for drug use
patient education handout
pneumonia, viral
coronavirus infections
pandemics
coronavirus infections
alanine
alanine
ribonucleotides
COVID-19

---
https://www.cochrane.org/fr/CD011694/SYMPT_produits-base-de-cannabis-pour-les-personnes-atteintes-de-fibromyalgie
2020
false
false
false
France
United Kingdom
treatment outcome
nabilone
adult
cannabinoids
review of literature
french abstract
fibromyalgia
dronabinol
dronabinol

---
https://www.ema.europa.eu/en/medicines/human/EPAR/veklury
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
remdesivir
remdesivir
Remdesivir
adult
adolescent
infusions, intravenous
antiviral agents
antiviral agents
RNA Polymerase Inhibitor
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
oxygen inhalation therapy
remdesivir
alanine
alanine
ribonucleotides
alanine
ribonucleotides
pneumonia, viral
coronavirus infections
pandemics
coronavirus infections
COVID-19

---
Remdesivir authorized with conditions for the treatment of patients in Canada with severe COVID-19 symptoms
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2020/73621a-fra.php
2020
false
false
false
Canada
French
English
drug information
drug approval
canada
oxygen inhalation therapy
remdesivir
Remdesivir
adult
adolescent
infusions, intravenous
antiviral agents
product surveillance, postmarketing
pneumonia, viral
coronavirus infections
pandemics
coronavirus infections
alanine
alanine
ribonucleotides
COVID-19

---
https://www.has-sante.fr/jcms/p_3196682/fr/trecondi
2020
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
treosulfan
treosulfan
infusions, intravenous
drug therapy, combination
fludarabine
transplantation conditioning
hematopoietic stem cell transplantation
allografts
child
infant
adolescent
adult
hematologic neoplasms
treosulfan
busulfan
busulfan
busulfan
vidarabine
vidarabine

---
https://www.has-sante.fr/jcms/p_3199395/fr/adontex
2020
false
false
false
France
French
evaluation of the transparency committee
mouthwashes
insurance, health, reimbursement
adult
child
chlorhexidine gluconate
chlorhexidine
anti-infective agents, local
periodontal diseases
gingivitis
periodontitis
preoperative care
postoperative care
administration, topical
chlorhexidine
chlorhexidine

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=897
2020
false
false
false
France
coronavirus infections
pneumonia, viral
Remdesivir
antiviral agents
public health guidelines
remdesivir
pneumonia, viral
coronavirus infections
pandemics
alanine
alanine
ribonucleotides
COVID-19

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=899
2020
false
false
false
France
coronavirus infections
pneumonia, viral
risk factors
prognosis
severity of illness index
comorbidity
anti-bacterial agents
azithromycin
amoxicillin-potassium clavulanate combination
ceftriaxone
glucocorticoids
extracorporeal membrane oxygenation
ventilation, mechanical
antiviral agents
drug interactions
lopinavir-ritonavir drug combination
hydroxychloroquine
Remdesivir
remdesivir
convalescent plasma
immunologic factors
chloroquine
tocilizumab
Interleukin Inhibitor
practice guideline
public health guidelines
patient care management
respiration, artificial
pneumonia, viral
coronavirus infections
pandemics
Betacoronavirus
pneumonia, viral
coronavirus infections
pandemics
pneumonia, viral
coronavirus infections
pandemics
pneumonia, viral
coronavirus infections
pandemics
ritonavir
lopinavir
drug combinations
alanine
alanine
ribonucleotides
immunization, passive
antibodies, monoclonal, humanized
COVID-19
COVID-19
COVID-19
COVID-19
COVID-19

---
https://www.ansm.sante.fr/actualites/la-production-la-vente-et-lachat-de-phenibut-un-psychotrope-de-synthese-sont-desormais-interdits
2020
false
false
false
France
French
legislation, drug
4-amino-3-phenylbutyric acid
4-amino-3-phenylbutyric acid
vigilance note
GABA agonists
GABA agonists
gamma-aminobutyric acid
gamma-aminobutyric acid
gamma-aminobutyric acid

---
https://www.has-sante.fr/jcms/p_3201793/fr/veklury
2020
false
false
false
France
Remdesivir
remdesivir
treatment outcome
infusions, intravenous
insurance, health, reimbursement
adolescent
antiviral agents
remdesivir
evaluation of the transparency committee
alanine
alanine
ribonucleotides
pneumonia, viral
coronavirus infections
pandemics
coronavirus infections
COVID-19

---
https://www.has-sante.fr/jcms/p_3202351/fr/oratoria
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
dexamethasone 21-phosphate
glucocorticoids
ophthalmic solutions
administration, ophthalmic
dexamethasone
inflammation of anterior eye segment
inflammation
eye diseases
evaluation of the transparency committee
dexamethasone
dexamethasone

---
https://www.has-sante.fr/jcms/p_3202542/fr/gemcitabine-hikma
2020
false
false
false
France
infusions, intravenous
gemcitabine
antimetabolites, antineoplastic
evaluation of the transparency committee
gemcitabine
deoxycytidine

---
https://www.has-sante.fr/jcms/p_3192396/fr/scenesse
2020
false
false
false
France
afamelanotide
afamelanotide
insurance, health, reimbursement
treatment outcome
drug implants
dermatologic agents
protoporphyria, erythropoietic
phototoxicity
adult
Product containing only afamelanotide in subcutaneous dose form (medicinal product form)
rare diseases
evaluation of the transparency committee
dermatitis, phototoxic
alpha-msh
alpha-msh

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61447165
2020
false
false
false
France
French
summary of product characteristics
package leaflet
drug combinations
administration, oral
doxylamine succinate
Pyridoxine Hydrochloride
histamine h1 antagonists
vitamin B complex
doxylamine, combinations
pregnancy
nausea
vomiting
Pregnancy-Related Nausea and/or Vomiting
pyridoxine
doxylamine
doxylamine

---
https://www.has-sante.fr/jcms/p_3210097/fr/serecor
2020
false
false
false
France
French
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
hydroquinidine
hydroquinidine hydrochloride
anti-arrhythmia agents
brugada syndrome
arrhythmias, cardiac
recurrence
hydroquinidine
quinidine
quinidine

---
https://www.ansm.sante.fr/actualites/valproate-de-sodium-et-derives-un-nouvel-outil-pratique-pour-les-pharmaciens
2020
false
false
false
France
French
professional role
pharmacists
guideline
valproate sodium
dipropylacetamide
Divalproex Sodium
pregnancy
anticonvulsants
teratogens
abnormalities, drug-induced
Woman of childbearing potential
valproic acid
valproic acid

---
https://www.has-sante.fr/jcms/p_3224404/fr/harvoni
2020
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
administration, oral
ledipasvir, sofosbuvir drug combination
Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form)
antiviral agents
hepatitis C, chronic
child
adolescent
adult
sofosbuvir and ledipasvir
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate

---
https://www.has-sante.fr/jcms/p_3225401/fr/besremi
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
Ropeginterferon Alfa-2B
Ropeginterferon Alfa-2B
ropeginterferon alfa-2b
peginterferon alfa-2b
injections, subcutaneous
adult
polycythemia vera
evaluation of the transparency committee
interferon-alpha
recombinant proteins
Interferon alpha-2
polyethylene glycols

---
https://www.has-sante.fr/jcms/p_3152698/fr/zerbaxa
2020
false
false
false
France
French
treatment outcome
insurance, health, reimbursement
ceftolozane, tazobactam drug combination
drug combinations
ceftolozane
anti-bacterial agents
Tazobactam
ceftolozane and beta-lactamase inhibitor
beta-Lactamase Inhibitors
evaluation of the transparency committee
pseudomonas aeruginosa
pseudomonas infections
Infection Pseudomonas aeruginosa
cephalosporins
penicillanic acid
penicillanic acid

---
https://www.ema.europa.eu/en/medicines/human/EPAR/lysakare
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
drug combinations
arginine
arginine
lysine
lysine
radiation injuries
kidney diseases
lutetium Lu 177 dotatate
infusions, intravenous
adult
pregnancy
breast feeding
protective agents
protective agents
arginine and lysine
organometallic compounds
octreotide
octreotide

---
https://www.cochrane.org/fr/CD001417/le-topiramate-en-traitement-dappoint-pour-lepilepsie-focale-resistante-aux-medicaments
2019
false
false
false
France
United Kingdom
meta-analysis
french abstract
anticonvulsants
topiramate
Drug Resistant Epilepsy
epilepsies, partial
fructose
fructose
Topiramate

---
https://www.has-sante.fr/jcms/p_3097607/fr/ravicti
2019
false
false
false
France
infant, newborn
administration, oral
glycerol phenylbutyrate
urea cycle disorders, inborn
treatment outcome
glycerol phenylbutyrate
evaluation of the transparency committee
phenylbutyrates
glycerol
glycerol

---
https://www.has-sante.fr/jcms/p_3104691/fr/yargesa
2019
false
false
false
France
drugs, generic
miglustat
evaluation of the transparency committee
1-Deoxynojirimycin
1-Deoxynojirimycin

---
https://www.has-sante.fr/jcms/c_2909822/fr/previscan
2019
false
false
false
France
evaluation of the transparency committee
previscan
fluindione
phenindione
fluindione
phenindione
phenindione

---
https://www.usherbrooke.ca/baladocritique/archives/episode-26-etude-rewind/
2019
false
false
false
false
Canada
immunoglobulin fc fragments
glucagon-like peptides
recombinant fusion proteins
cardiovascular diseases
treatment outcome
hypoglycemic agents
Glucagon-Like Peptide-1 Receptor
sound
diabetes mellitus, type 2
dulaglutide

---
https://www.has-sante.fr/jcms/p_3111988/fr/daivobet-xamiol
2019
false
false
false
France
drug combinations
betamethasone dipropionate, calcipotriol drug combination
insurance, health, reimbursement
evaluation of the transparency committee
betamethasone
betamethasone
calcitriol
calcitriol
drug combinations

---
https://www.inspq.qc.ca/publications/2606
2019
false
false
false
Canada
fentanyl
technical report
occupational exposure
fentanyl

---
https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Hormonotherapie-enzalutamide
2019
false
false
false
France
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
continuity of patient care
risk factors
patient education as topic
prostatic neoplasms, Castration-Resistant
enzalutamide
androgen antagonists
androgen receptor antagonists
antineoplastic agents, hormonal
antineoplastic agents, hormonal
administration, oral
neoplasm metastasis
Common Terminology Criteria for Adverse Events
hypertension
long qt syndrome
seizures
headache disorders
fatigue
leukopenia
neutropenia
thrombocytopenia
drug interactions
guidelines for drug use
phenylthiohydantoin
enzalutamide
enzalutamide
phenylthiohydantoin
phenylthiohydantoin
phenylthiohydantoin

---
https://www.has-sante.fr/jcms/p_3122215/fr/miglustat-accord
2019
false
false
false
France
miglustat
Niemann-Pick disease, type C
adult
treatment outcome
insurance, health, reimbursement
drugs, generic
administration, oral
child
adolescent
evaluation of the transparency committee
miglustat
1-Deoxynojirimycin

---
https://www.has-sante.fr/jcms/p_3123997/fr/colobreathe
2019
false
false
false
France
colistimethate sodium
colistin
pneumonia, bacterial
chronic disease
cystic fibrosis
pseudomonas infections
anti-bacterial agents
child
adolescent
adult
treatment outcome
insurance, health, reimbursement
administration, inhalation
evaluation of the transparency committee
colistinmethanesulfonic acid
colistin
colistin

---
https://www.ema.europa.eu/en/medicines/human/EPAR/qtrilmet
2019
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
metformin
dapagliflozin
saxagliptin
Metformin Hydrochloride
Metformin Hydrochloride
hypoglycemic agents
hypoglycemic agents
drug approval
europe
metformin, saxagliptin and dapagliflozin
diabetes mellitus, type 2
adult
administration, oral
incretins
incretins
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
Sodium-Glucose Transporter 2 Inhibitors
Sodium-Glucose Transporter 2 Inhibitors
Glycated Hemoglobin
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
dapagliflozin
metformin
dapagliflozin
saxagliptin
dapagliflozin
dipeptides
adamantane
glucosides
benzhydryl compounds
dapagliflozin
dipeptides
glucosides
benzhydryl compounds

---
https://www.ema.europa.eu/en/medicines/human/EPAR/rhokiinsa
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
adult
administration, ophthalmic
glaucoma, open-angle
ocular hypertension
rho-Associated kinases
product surveillance, postmarketing
ophthalmic solutions
pregnancy
breast feeding
netarsudil
drug evaluation, preclinical
Product containing only netarsudil in ocular dose form (medicinal product form)
netarsudil
netarsudil
benzoates
beta-Alanine
beta-Alanine
benzoates
beta-Alanine

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/usage-de-la-rifapentine-pour-le-traitement-de-linfection-tuberculeuse-latente.html
2019
false
false
false
Canada
drug therapy, combination
isoniazid
antitubercular agents
antibiotics, antitubercular
rifapentine
antibiotics, antitubercular
review of literature
drug information
rifapentine
latent tuberculosis
rifampin

---
https://www.cochrane.org/fr/CD009359/racecadotril-pour-traiter-les-enfants-de-moins-de-cinq-ans-atteints-de-diarrhee-aigue
2019
false
false
false
France
United Kingdom
infant
child
diarrhea
racecadotril
antidiarrheals
treatment outcome
review of literature
french abstract
thiorphan
thiorphan

---
https://www.sfdermato.org/media/pdf/recommandation/prise-en-charge-de-urticaire-chronique-spontanee-471b6ebe79d8a3e8103790b3250d1aa5.pdf
2019
false
false
false
France
chronic disease
Chronic spontaneous urticaria
desloratadine
urticaria
histamine h1 antagonists
case reports
Omalizumab
cyclosporine
overweight
angioedema
dexchlorpheniramine
drug therapy, combination
risk factors
cetirizine
levocetirizine
adult
child
pregnancy
practice guideline
urticaria
patient care management
loratadine
loratadine
chlorpheniramine

---
https://www.has-sante.fr/portail/jcms/c_2891867/fr/spasfon
2019
false
false
false
France
French
treatment outcome
phloroglucinol
1,3,5-trimethoxybenzene
drug combinations
injections
phloroglucinol
evaluation of the transparency committee
phloroglucinol

---
https://www.has-sante.fr/portail/jcms/c_2893495/fr/treprostinil-reddy-pharma?xtmc=&xtcr=30
2019
false
false
false
France
French
treatment outcome
treprostinil
evaluation of the transparency committee
epoprostenol
epoprostenol

---
https://www.has-sante.fr/portail/jcms/c_2899211/fr/chloraprep-colore-chloraprep
2019
false
false
false
France
insurance, health, reimbursement
treatment outcome
drug combinations
chlorhexidine gluconate
2-Propanol
administration, cutaneous
anti-infective agents, local
chlorhexidine, combinations
vascular catheters
antisepsis
evaluation of the transparency committee
vascular access devices
chlorhexidine
chlorhexidine

---
https://www.has-sante.fr/portail/jcms/c_2898719/fr/dexliq
2019
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
pharmaceutical solutions
dexamethasone sodium phosphate
dexamethasone
glucocorticoids
evaluation of the transparency committee
dexamethasone 21-phosphate
dexamethasone
dexamethasone

---
https://www.has-sante.fr/portail/jcms/c_2899210/fr/diprosalic
2019
false
France
French
evaluation of the transparency committee
corticosteroid therapy
betamethasone dipropionate, salicylic acid drug combination
administration, cutaneous
salicylic acid
betamethasone
anti-inflammatory agents
betamethasone-17,21-dipropionate
psoriasis
lichenoid eruptions
dermatitis, seborrheic
betamethasone
treatment outcome
administration, topical
scalp dermatoses
adult
insurance, health, reimbursement
drug combinations
salicylates

---
https://www.has-sante.fr/portail/jcms/c_2902384/fr/elunir
2019
false
false
false
France
Drug-Eluting stents
coronary disease
treatment outcome
health technology assessment
ridaforolimus
sirolimus

---
https://www.has-sante.fr/portail/jcms/c_2904834/fr/frakidex
2019
false
false
false
France
Neomycin B Sulfate
drug combinations
dexamethasone sodium phosphate
evaluation of the transparency committee
framycetin
dexamethasone 21-phosphate
dexamethasone
dexamethasone

---
Health Canada recommends that children and youth not use cough and cold products that contain opioids
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69080a-fra.php
2019
false
false
false
Canada
French
English
child
adolescent
antitussive agents
codeine
hydrocodone
cough
common cold
normethadone
opioid-related disorders
opium alkaloids and derivatives
risk
pharmacovigilance note
methadone
methadone

---
https://www.cochrane.org/fr/CD012167/les-antihistaminiques-h1-sous-forme-de-comprimes-ou-liquide-aident-ils-ameliorer-les-symptomes-de
2019
false
false
false
France
United Kingdom
eczema
treatment outcome
comparative effectiveness research
administration, oral
administration, cutaneous
histamine h1 antagonists
histamine h1 antagonists
fexofenadine
loratadine
cetirizine
placebos
review of literature
french abstract
terfenadine
terfenadine

---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/folotyn-lymphome-t-peripherique-4626.html
2019
false
false
false
Canada
French
drug evaluation
pralatrexate
pralatrexate
lymphoma, T-Cell, peripheral
injections, intravenous
antimetabolites, antineoplastic
10-propargyl-10-deazaaminopterin
aminopterin
aminopterin

---
https://www.has-sante.fr/portail/jcms/c_2908450/fr/chlorhexidine-biogaran
2019
false
true
false
false
France
chlorhexidine gluconate
chlorhexidine
mouthwashes
anti-infective agents, local
administration, oral
Oral infection (disorder)
adult
child
chlorhexidine
insurance, health, reimbursement
evaluation of the transparency committee
chlorhexidine
chlorhexidine

---
https://www.has-sante.fr/portail/jcms/c_2908487/fr/signifor
2019
true
false
France
French
evaluation of the transparency committee
acromegaly
pituitary acth hypersecretion
pasireotide
orphan drug production
pasireotide
adult
somatostatin
injections, intramuscular
aged
insurance, health, reimbursement
treatment outcome
risk management
product surveillance, postmarketing

---
https://www.has-sante.fr/portail/jcms/c_2909822/fr/previscan
https://www.has-sante.fr/portail/jcms/c_2909822/fr/previscan-fluindione-antivitamine-k
2019
false
true
false
false
France
fluindione
administration, oral
insurance, health, reimbursement
treatment outcome
fluindione
thromboembolism
arrhythmias, cardiac
heart valve diseases
myocardial infarction
deep vein thrombosis
deep vein thrombosis
recurrence
pulmonary embolism
pulmonary embolism
anticoagulants
vitamin K
guidelines for drug use
evaluation of the transparency committee
venous thrombosis
venous thrombosis
recurrence
phenindione
phenindione

---
https://www.ema.europa.eu/en/medicines/human/EPAR/rizmoic
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
naldemedine
naldemedine
analgesics, opioid
administration, oral
receptors, opioid, kappa
receptors, opioid, delta
receptors, opioid, mu
product surveillance, postmarketing
adult
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
naldemedine
Opioid-Induced Constipation
naltrexone
naltrexone
naltrexone

---
https://www.has-sante.fr/portail/jcms/c_2909812/fr/ferinject
https://www.has-sante.fr/portail/jcms/c_2909812/fr/ferinject-carboxymaltose-ferrique-preparation-martiale
2019
false
true
false
false
France
French
ferric carboxymaltose
ferric compounds
maltose
Iron deficiency (disorder)
anemia, iron-deficiency
adult
heart failure
ferric compounds
maltose
ferric compounds
maltose
guidelines for drug use
iron, parenteral preparations
injections, intravenous
infusions, intravenous
deficiency diseases
iron
evaluation of the transparency committee
Ferinject

---
https://www.has-sante.fr/portail/jcms/c_2913097/fr/myalepta
https://www.has-sante.fr/portail/jcms/c_2913097/fr/myalepta-metreleptine-analogue-recombinant-de-la-leptine-humaine
2019
false
true
false
false
France
French
treatment outcome
orphan drug production
metreleptin
metreleptin
lipodystrophy, congenital generalized
lipodystrophy, familial partial
adult
adolescent
Acquired partial lipodystrophy
Acquired generalized lipodystrophy
injections, subcutaneous
leptin
evaluation of the transparency committee
insurance, health, reimbursement
survival analysis
leptin
leptin
guidelines for drug use

---
https://www.has-sante.fr/portail/jcms/c_2912811/fr/resolute-integrity
2019
false
true
false
false
France
coronary disease
treatment outcome
stents
coronary disease
health technology assessment
zotarolimus
stents
sirolimus

---
https://www.ansm.sante.fr/actualites/antiepileptiques-au-cours-de-la-grossesse-etat-actuel-des-connaissances-sur-les-risques-de-malformations-et-de-troubles-neuro-developpementaux
2019
false
false
false
France
French
maternal exposure
anticonvulsants
abnormalities, drug-induced
Neurodevelopmental Disorders
risk
valproic acid
valproic acid antenatal infection
drug information
technical report
carbamazepine
eslicarbazepine
ethosuximide
epilepsy
Felbamate
Gabapentin
Lacosamide
Lamotrigine
Levetiracetam
Oxcarbazepine
perampanel
contraception
primidone
phenobarbital
phenytoin
fosphenytoin
Pregabalin
ezogabine
rufinamide
Tiagabine
Topiramate
vigabatrin
Zonisamide
infant, newborn
dibenzazepines
pyridones
phenytoin
carbamates
phenylenediamines
triazoles

---
https://www.has-sante.fr/portail/jcms/c_2965047/fr/adynovi
https://www.has-sante.fr/portail/jcms/c_2965047/fr/adynovi-rurioctocog-alfa-pegol-facteur-anti-hemophilique-facteur-viii
2019
false
false
false
France
French
treatment outcome
hemophilia A
hemorrhage
hemorrhage
adult
adolescent
aged
injections, intravenous
factor VIII
recombinant proteins
coagulation factor VIII
evaluation of the transparency committee
guidelines for drug use

---
https://www.ema.europa.eu/en/medicines/human/EPAR/besremi
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Ropeginterferon Alfa-2B
Ropeginterferon Alfa-2B
peginterferon alfa-2b
drug approval
europe
polycythemia vera
adult
ropeginterferon alfa-2b
orphan drug production
injections, subcutaneous
receptor, interferon alpha-beta
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
interferon-alpha
recombinant proteins
Interferon alpha-2
polyethylene glycols

---
https://www.ema.europa.eu/en/medicines/human/EPAR/miglustat-dipharma
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
adult
drugs, generic
drug approval
europe
miglustat
miglustat
gaucher disease, type 1
administration, oral
enzyme inhibitors
enzyme inhibitors
ceramide glucosyltransferase
drug interactions
pregnancy
breast feeding
miglustat
gaucher disease
1-Deoxynojirimycin
1-Deoxynojirimycin
1-Deoxynojirimycin
glucosyltransferases

---
https://www.has-sante.fr/portail/jcms/c_2967172/fr/atosiban-accord
2019
false
false
false
France
atosiban
treatment outcome
insurance, health, reimbursement
threatened premature labor
obstetric labor, premature
adult
pregnancy
evaluation of the transparency committee
atosiban
vasotocin
vasotocin

---
https://www.anses.fr/fr/system/files/EAUX2016SA0135.pdf
2019
false
false
false
France
water pollution
risk assessment
drug residues
drinking water
diclofenac
water quality
Dietary Exposure
4'-hydroxydiclofenac
5-hydroxydiclofenac
technical report
diclofenac
water consumption
risk
drinking
diclofenac

---
Prostacyclin in pulmonary arterial hypertension
https://www.cochrane.org/fr/CD012785/la-prostacycline-dans-lhypertension-arterielle-pulmonaire
2019
false
true
false
false
France
United Kingdom
French
English
selexipag
receptors, prostaglandin
epoprostenol
infusions, intravenous
administration, oral
administration, inhalation
injections, subcutaneous
Evidence-Based medicine
treatment outcome
hypertension, pulmonary
review of literature
french abstract
hypertension, pulmonary
epoprostenol
acetamides
pyrazines

---
https://www.has-sante.fr/portail/jcms/c_2971786/fr/cartrex
2019
true
France
French
treatment outcome
risk factors
aceclofenac
cardiovascular diseases
risk assessment
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
osteoarthritis
arthritis, rheumatoid
spondylitis, ankylosing
anti-inflammatory agents, non-steroidal
aceclofenac
diclofenac
aceclofenac

---
https://www.louvainmedical.be/fr/article/les-biotherapies-dans-le-traitement-du-psoriasis-modere-severe
2019
false
false
false
Belgium
biological therapy
psoriasis
antibodies, monoclonal
apremilast
biological therapy
continuity of patient care
journal article
thalidomide
thalidomide

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00433
2019
false
false
false
Canada
French
drug information
drug approval
canada
treatment outcome
lutetium Lu 177 dotatate
lutetium Lu 177 dotatate
lutetium (177Lu) oxodotreotide
radiopharmaceuticals
radiopharmaceuticals
injections, intravenous
gastro-enteropancreatic neuroendocrine tumor
adult
disease progression
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide
intestinal neoplasms
pancreatic neoplasms
stomach neoplasms
neuroendocrine tumors

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00427
2019
false
false
false
Canada
French
drug information
drug approval
canada
pralatrexate
pralatrexate
pralatrexate
injections, intravenous
lymphoma, T-Cell, peripheral
antineoplastic agents
antineoplastic agents
treatment outcome
10-propargyl-10-deazaaminopterin
10-propargyl-10-deazaaminopterin
aminopterin
aminopterin
aminopterin

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00414
2019
false
false
false
Canada
French
drug information
drug approval
canada
telotristat etiprate
telotristat etiprate
telotristat
telotristat
treatment outcome
administration, oral
tryptophan hydroxylase
adult
aged
diarrhea
malignant carcinoid syndrome
telotristat
drug therapy, combination
phenylalanine
phenylalanine
pyrimidines
phenylalanine
pyrimidines

---
https://www.ema.europa.eu/en/medicines/human/EPAR/trecondi
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treosulfan
treosulfan
transplantation conditioning
hematopoietic stem cell transplantation
allografts
adult
adolescent
infant
child
orphan drug production
infusions, intravenous
drug therapy, combination
antineoplastic agents, alkylating
antineoplastic agents, alkylating
pregnancy
breast feeding
fertility
treosulfan
survival analysis
drug evaluation, preclinical
busulfan
busulfan
busulfan

---
https://www.has-sante.fr/portail/jcms/c_1759931/fr/contraception-estroprogestative-transdermique-ou-vaginale-dispensation-en-officine
2019
false
false
false
France
French
guideline
administration, cutaneous
administration, intravaginal
transdermal patch
vaginal ring with progestogen and estrogen
contraception
drug combinations
ethinyl estradiol
progestins
professional role
pharmacists
contraceptive devices, female
vaginal rings
drug interactions
Ortho Evra
norelgestromin and ethinylestradiol
NuvaRing
minors
drug prescriptions
contraceptive devices, female
counseling
Contraindications, Procedure
norgestrel
norgestrel
drug combinations
desogestrel
desogestrel

---
https://www.has-sante.fr/jcms/pprd_2982834/fr/ferinject
2019
false
true
false
false
France
anemia, iron-deficiency
ferric compounds
ferric compounds
treatment outcome
evaluation of the transparency committee
Ferinject
ferric carboxymaltose
ferric compounds
maltose

---
https://www.ansm.sante.fr/actualites/reduction-du-risque-lie-a-lexposition-au-mycophenolate-au-cours-de-la-grossesse-mise-a-disposition-des-guides-et-du-formulaire-daccord-de-soins-actualises
2018
false
false
false
France
French
pharmacovigilance note
teratogens
drugs, generic
mycophenolic acid
Mycophenolate Sodium
legislation, drug
drug prescriptions
patient education as topic
guidelines for drug use
pregnancy
risk management
risk
contraception
Mycophenolate Sodium
male contraception
female contraception
risk reduction
Drug-Related side effects and adverse reactions
Exposure during pregnancy
patients guideline
forms
Contraindications, Procedure
mycophenolic acid
mycophenolic acid
mycophenolic acid
risk reduction behavior
Contraindications, Drug

---
https://www.has-sante.fr/portail/jcms/c_2862069/fr/rydapt-lam
2018
false
false
false
false
France
French
evaluation of the transparency committee
midostaurin
midostaurin
treatment outcome
midostaurin
administration, oral
antineoplastic agents
antineoplastic agents
adult
antineoplastic combined chemotherapy protocols
leukemia, myeloid, acute
FLT3 Gene Mutation
leukemia, myeloid, acute
staurosporine
staurosporine
staurosporine

---
https://www.has-sante.fr/portail/jcms/c_2847939/fr/vemlidy
2018
false
false
false
France
French
antiviral agents
treatment outcome
tenofovir alafenamide
adult
adolescent
hepatitis B, chronic
administration, oral
reverse transcriptase inhibitors
aged
evaluation of the transparency committee
insurance, health, reimbursement
tenofovir alafenamide
tenofovir alafenamide
adenine

---
https://ansm.sante.fr/informations-de-securite/Valproate-et-derives-contre-indication-pendant-la-grossesse-sauf-situations-exceptionnelles-et-programme-de-prevention-des-grossesses
2018
false
false
false
France
French
Divalproex Sodium
pregnancy
valproate sodium
valproic acid
valpromide
dipropylacetamide
anticonvulsants
abnormalities, drug-induced
prenatal exposure delayed effects
continuity of patient care
contraception
adult
adolescent
women
maternal exposure
guidelines for drug use
-
risk reduction behavior
product surveillance, postmarketing
Obstetrician (occupation)
Gynecologist (occupation)
Contraindications, Procedure
valproic acid
valproic acid
Contraindications, Drug

---
https://www.cochrane.org/fr/CD005061/les-inhibiteurs-de-lalpha-glucosidase-pour-prevenir-ou-retarder-lapparition-du-diabete-de-type-2-et
2018
false
false
false
France
United Kingdom
alpha-Glucosidase Inhibitors
diabetes mellitus, type 2
risk
acarbose
voglibose
hypoglycemic agents
diabetes complications
review of literature
french abstract
Glycoside Hydrolase Inhibitors
inositol
inositol

---
https://pharmacomedicale.org/medicaments/par-specialites/item/medicaments-des-vertiges
2018
false
true
false
France
meclizine
betahistine
piracetam
acetylleucine
drug information
vertigo
leucine
leucine

---
https://www.has-sante.fr/portail/jcms/c_2861089/fr/rydapt-mastocytose
https://www.has-sante.fr/portail/jcms/c_2861089/fr/rydapt-midostaurine-inhibiteur-de-tyrosine-kinase-mastocytose
2018
false
false
false
false
France
French
evaluation of the transparency committee
administration, oral
aggressive systemic mastocytosis
midostaurin
midostaurin
treatment outcome
midostaurin
Systemic mastocytosis with associated hematologic neoplasm
leukemia, mast-cell
guidelines for drug use
mastocytosis, systemic
staurosporine
staurosporine
staurosporine

---
https://www.has-sante.fr/portail/jcms/c_2848077/fr/harvoni-sofosbuvir/ledipasvir-antiviral-a-action-directe
https://www.has-sante.fr/portail/jcms/c_2848077/fr/harvoni
2018
false
false
false
France
French
evaluation of the transparency committee
administration, oral
treatment outcome
drug combinations
benzimidazoles
benzimidazoles
fluorenes
fluorenes
antiviral agents
antiviral agents
hepatitis C, chronic
guidelines for drug use
insurance, health, reimbursement
ledipasvir
ledipasvir
Sofosbuvir
Sofosbuvir
ledipasvir, sofosbuvir drug combination
ledipasvir, sofosbuvir drug combination
sofosbuvir and ledipasvir
adolescent
uridine monophosphate
uridine monophosphate
uridine monophosphate

---
https://www.has-sante.fr/portail/jcms/c_2855997/fr/ravicti
https://www.has-sante.fr/portail/jcms/c_2855997/fr/ravicti-phenylbutyrate-de-glycerol-medicament-des-voies-digestives-et-du-metabolisme
2018
false
false
false
France
French
treatment outcome
glycerol phenylbutyrate
glycerol phenylbutyrate
urea cycle disorders, inborn
adult
adolescent
child
infant
carbamoyl-phosphate synthase i deficiency disease
ornithine carbamoyltransferase deficiency disease
argininosuccinic aciduria
hyperargininemia
citrullinemia
HHH syndrome
administration, oral
Enteral Route of Administration
Gastroenteral route (qualifier value)
evaluation of the transparency committee
guidelines for drug use
ornithine
hyperammonemia
phenylbutyrates
glycerol
glycerol

---
https://www.has-sante.fr/portail/jcms/c_2864194/fr/lutathera
2018
false
false
false
France
French
neuroendocrine tumors
intestinal neoplasms
radiopharmaceuticals
neoplasm metastasis
lutetium Lu 177 dotatate
lutetium
adult
infusions, intravenous
treatment outcome
lutetium (177Lu) oxodotreotide
antineoplastic agents
evaluation of the transparency committee
survival analysis
neuroendocrine tumors
intestinal neoplasms
organometallic compounds
octreotide
octreotide

---
Myalepta metreleptin
https://www.ema.europa.eu/medicines/human/EPAR/Myalepta
2018
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
orphan drug production
metreleptin
metreleptin
metreleptin
drug approval
europe
lipodystrophy, congenital generalized
lipodystrophy, familial partial
adult
adolescent
Acquired partial lipodystrophy
Acquired generalized lipodystrophy
injections, subcutaneous
leptin
drug interactions
pregnancy
drug evaluation, preclinical

---
https://www.has-sante.fr/portail/jcms/c_2867425/fr/fulvestrant-teva
2018
false
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
fulvestrant
estradiol
Fulvestrant

---
2018
false
France
French
child
adolescent
icatibant acetate
icatibant acetate
icatibant
orphan drug production
injections, subcutaneous
icatibant
bradykinin
hereditary angioedema types I and II
acute disease
emergency treatment
treatment outcome
icatibant
evaluation of the transparency committee

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00383
2018
false
false
false
Canada
French
English
drug information
lifitegrast
drug evaluation
drug approval
canada
lymphocyte Function-Associated Antigen-1
dry eye syndromes
adult
aged
administration, ophthalmic
ophthalmic solutions
treatment outcome
risk assessment
lifitegrast
product surveillance, postmarketing
lifitegrast
sulfones
phenylalanine
sulfones
phenylalanine
phenylalanine
sulfones
phenylalanine

---
https://www.ema.europa.eu/medicines/human/EPAR/Veyvondi
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
von Willebrand factor
product surveillance, postmarketing
hemorrhage
blood loss, surgical
blood loss, surgical
von willebrand diseases
von willebrand factor
injections, intravenous
adult
pregnancy
breast feeding
recombinant proteins
drug evaluation, preclinical

---
https://phc.swisshealthweb.ch/fr/article/doi/phc-f.2018.01804/
https://doi.org/10.4414/phc-f.2018.01804
2018
false
false
false
Switzerland
French
journal article
anticonvulsants
anticonvulsants
drug interactions
epilepsy
guidelines for drug use
valproate sodium
carbamazepine
levetiracetam
Pregabalin
perampanel
continuity of patient care
drug prescriptions
pregnancy
breast feeding
valproic acid
piracetam
piracetam
amines
cyclohexanecarboxylic acids
gamma-aminobutyric acid
triazines
fructose
fructose
carbamazepine
isoxazoles
acetamides
pyridones
Gabapentin
Lamotrigine
Topiramate
Levetiracetam
Zonisamide
Oxcarbazepine
Lacosamide

---
https://www.has-sante.fr/portail/jcms/c_2873704/fr/firazyr
https://www.has-sante.fr/portail/jcms/c_2873704/fr/firazyr-icatibant
2018
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
icatibant acetate
icatibant
guidelines for drug use
hereditary angioedema types I and II
adult
icatibant
bradykinin
bradykinin

---
https://www.has-sante.fr/portail/jcms/c_2872648/fr/selincro
2018
false
false
false
false
France
French
evaluation of the transparency committee
nalmefene hydrochloride
nalmefene
nalmefene
naltrexone
naltrexone

---
https://www.has-sante.fr/portail/jcms/c_2873713/fr/ruconest
2018
false
France
English
French
evaluation of the transparency committee
adolescent
acute disease
angioedemas, hereditary
complement inactivating agents
orphan drug production
injections, intravenous
treatment outcome
conestat alfa
complement C1 inhibitor protein
complement C1 inhibitor protein
recombinant proteins
conestat alfa

---
https://www.ema.europa.eu/en/medicines/human/EPAR/lenalidomide-accord
2018
false
United Kingdom
English
French
syndication feed
drugs, generic
antineoplastic combined chemotherapy protocols
drug approval
europe
drug interactions
pregnancy
breast feeding
treatment outcome
drug evaluation
antineoplastic agents
drug therapy, combination
multiple myeloma
adult
thalidomide
lenalidomide
antineoplastic agents
drug evaluation
summary of product characteristics
package leaflet
Lenalidomide
Lenalidomide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66942259
2018
false
false
false
France
French
summary of product characteristics
package leaflet
contraceptives, oral, combined
contraception
acne vulgaris
ethinyl estradiol
ethinyl estradiol
drug combinations
dienogest
dienogest
contraceptives, oral
contraceptives, oral
androgen antagonists
androgen antagonists
dienogest and ethinylestradiol
antiandrogens and estrogens
estrogens
estrogens
drug interactions
Contraindications, Drug
pregnancy
breast feeding
dienogest
dienogest
nandrolone
nandrolone
nandrolone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64091062
2018
false
false
false
France
French
summary of product characteristics
package leaflet
contraceptives, oral, combined
contraception
acne vulgaris
ethinyl estradiol
ethinyl estradiol
drug combinations
dienogest
dienogest
contraceptives, oral
contraceptives, oral
androgen antagonists
androgen antagonists
dienogest and ethinylestradiol
antiandrogens and estrogens
estrogens
estrogens
drug interactions
Contraindications, Drug
pregnancy
breast feeding
dienogest
dienogest
nandrolone
nandrolone
nandrolone

---
https://www.has-sante.fr/portail/jcms/c_2879339/fr/rydapt
2018
false
true
false
France
leukemia, myeloid, acute
midostaurin
antineoplastic agents
midostaurin
evaluation of the transparency committee
staurosporine
staurosporine

---
https://www.has-sante.fr/portail/jcms/c_2877305/fr/flector
2018
false
false
false
France
diclofenac hydroxyethylpyrrolidine
administration, oral
diclofenac
treatment outcome
crystal arthropathy, nos
osteoarthritis
radicular pain
rheumatic diseases
anti-inflammatory agents, non-steroidal
evaluation of the transparency committee
diclofenac
diclofenac

---
https://www.has-sante.fr/portail/jcms/c_2876782/fr/rapibloc
https://www.has-sante.fr/portail/jcms/c_2876782/fr/rapibloc-landiolol-betabloquant-cardio-selectif
2018
false
false
false
France
tachycardia, supraventricular
landiolol
landiolol
tachycardia, sinus
treatment outcome
guidelines for drug use
evaluation of the transparency committee
morpholines
urea
urea

---
http://grpso.org/upload/recommandations/file/Reco-pso-forum-JDP.pdf
2018
false
true
false
France
administration, oral
injections, subcutaneous
methotrexate
antibodies, monoclonal
cyclosporine
adult
practice guideline
acitretin
apremilast
psoriasis
thalidomide
thalidomide

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=695
2018
false
false
false
France
French
public health guidelines
hemorrhagic fever, ebola
hemorrhagic fever, ebola
health personnel
occupational exposure
Pre-Exposure Prophylaxis
Post-Exposure prophylaxis
ebola vaccines
antibodies, monoclonal
antiviral agents
ZMapp
Remdesivir
favipiravir
remdesivir
amides
pyrazines
alanine
alanine
ribonucleotides

---
Nous contacter.
30/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.